Nemolizumab Being Reviewed for AD, Prurigo Nodularis
For prurigo nodularis, the FDA has granted nemolizumab, a monoclonal antibody designed to inhibit interleukin-31 signaling, priority review.
Source: medscape.com
Page 8 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Linical Studies Today - Breaking & Trending Today
Dupilumab for EoE: How Is it Improving Treatment?
The drug was a boon for many patients, mainly those with moderate to severe disease, but cost and insurance approvals posed challenges.
Source: medscape.com
FDA Approves First Cellular Therapy for Metastatic Melanoma
Lifileucel is the first cellular therapy to be approved to treat patients with unresectable or metastatic melanoma.
Source: medscape.com
Nonablative RF Treatment Effective in Adults With Acne
The study is thought to be the first comprehensive analysis to evaluate NMRF as a treatment for acne, according to the authors.
Source: medscape.com
Salt Substitute Reduces Risk for New Hypertension
Among older adults with normal blood pressure, replacing table salt with salt substitute reduced the incidence of hypertension vs a usual salt group, in the DECIDE-Salt trial.
Source: medscape.com